cholestanol has been researched along with Cardiovascular Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Duarte, K; Fauler, G; Fellström, B; Girerd, N; Jardine, AG; März, W; Massy, ZA; Rossignol, P; Sadiku, S; Scharnagl, H; Schmieder, RE; Silbernagel, G; Zannad, F | 1 |
| Endress, G; Geller, AS; Schaefer, EJ | 1 |
| Bernalier-Donadille, A; Blond, E; Blot, A; Bodin, JP; Caille, A; Cheillan, D; Combe, E; Cotte, E; Domingues-Faria, C; Drai, J; Gaborit, P; Gésan-Guiziou, G; Joffre, F; Joumard-Cubizolles, L; Lambert-Porcheron, S; Laville, M; Le Barz, M; Lecomte, M; Malpuech-Brugère, C; Meiller, L; Michalski, MC; Morel-Laporte, F; Morio, B; Moulin, P; Ouchchane, L; Raynal, K; Sauvinet, V; Sothier, M; Vidal, H; Vors, C; Wauquier, A | 1 |
| Baumgartner, I; Drechsler, C; Fauler, G; Genser, B; Grammer, TB; Krane, V; März, W; Ritz, E; Scharnagl, H; Silbernagel, G; Wanner, C | 1 |
| Conceição, LL; Peluzio, MCG; Reis, SA; Rosa, DD; Siqueira, NP | 1 |
| Gylling, H; Hallikainen, M; Miettinen, TA; Raitakari, OT; Viikari, J | 1 |
| Boehm, BO; Fauler, G; Hoffmann, MM; Lütjohann, D; März, W; Silbernagel, G; Winkelmann, BR | 1 |
| Ishibashi, S; Kotani, K; Miyamoto, M; Nagasaka, S; Okada, K; Osuga, J; Yagyu, H | 1 |
| Amiot-Carlin, MJ; Defoort, C; Lairon, D; Nicolay, A; Portugal, H; Vergnes, MF; Wolff, E | 1 |
2 review(s) available for cholestanol and Cardiovascular Diseases
| Article | Year |
|---|---|
The biochemical and genetic diagnosis of lipid disorders.
Topics: Apolipoproteins; Biomarkers; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, LDL; Fasting; Gene Expression; Genetic Predisposition to Disease; High-Throughput Nucleotide Sequencing; Humans; Lipid Metabolism Disorders; Lipoprotein(a); Mutation; Pancreatitis; Receptors, Lipoprotein; Sitosterols; Triglycerides | 2019 |
Mechanisms responsible for the hypocholesterolaemic effect of regular consumption of probiotics.
Topics: Animals; Anticholesteremic Agents; Bacteria; Bile Acids and Salts; Cardiovascular Diseases; Cell Membrane; Chemical Precipitation; Cholestanol; Cholesterol; Dyslipidemias; Humans; Intestinal Absorption; Intestinal Mucosa; Lipid Metabolism; Probiotics | 2017 |
5 trial(s) available for cholestanol and Cardiovascular Diseases
| Article | Year |
|---|---|
High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study.
Topics: Atorvastatin; Cardiovascular Diseases; Cholestanol; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Renal Dialysis; Risk Factors; Rosuvastatin Calcium; Sterols | 2022 |
Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay.
Topics: Animals; Apolipoprotein A-I; Apolipoprotein B-100; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, HDL; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Emulsifying Agents; Feces; Female; Gastrointestinal Microbiome; Humans; Ileostomy; Intestinal Absorption; Lipid Metabolism; Lipids; Middle Aged; Milk; Overweight; Postmenopause; Risk Factors; Sphingomyelins | 2020 |
Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients.
Topics: Aged; Atorvastatin; Cardiovascular Diseases; Cholestanol; Cholesterol; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged; Pyrroles; Renal Dialysis | 2015 |
Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus.
Topics: Aged; Azetidines; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Ezetimibe; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Phytosterols; Sitosterols | 2010 |
Cholesterol-absorber status modifies the LDL cholesterol-lowering effect of a Mediterranean-type diet in adults with moderate cardiovascular risk factors.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cohort Studies; Diet, Mediterranean; Female; France; Humans; Hypercholesterolemia; Intestinal Absorption; Male; Middle Aged; Risk Factors; Severity of Illness Index; Young Adult | 2011 |
2 other study(ies) available for cholestanol and Cardiovascular Diseases
| Article | Year |
|---|---|
Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study.
Topics: Adolescent; Adult; Age Factors; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Child, Preschool; Cholestanol; Cholesterol; Chromatography, Gas; Chromatography, Liquid; Desmosterol; Female; Finland; Follow-Up Studies; Humans; Intestinal Absorption; Male; Phytosterols; Population Surveillance; Registries; Risk Factors; Sitosterols; Time Factors | 2009 |
The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality.
Topics: Absorption; Cardiovascular Diseases; Cholestanol; Cholesterol; Humans; Male; Middle Aged; Phytosterols; Prognosis; Risk; Sitosterols | 2010 |